All Biotech News

List of articles in category All Biotech News
Title	Published Date
Sartorius Stedim Biotech Introduces New SIMCA® 16 Software for Multivariate Data Analytics	05/08/2019
ESACT Inaugural Innovation Award to Honor ProBioGen’s CSO Dr. Volker Sandig	05/07/2019
WISE Enrols First Patient in Pivotal Clinical Study of Novel Neuro-Electrodes for Brain Monitoring	05/07/2019
Sartorius Stedim Biotech Launches New ambr® 15 Cell Culture Microbioreactor System	05/02/2019
AMAL Therapeutics Enters Clinical Collaboration with Boehringer Ingelheim to Evaluate ATP128 in Combination with BI754091	05/02/2019
Implandata Successfully Gains CE Mark for its EYEMATE System for an Orphan Eye Indication	04/29/2019
Shuwen Presents at The 2nd Companion Diagnostic & I-O Biomarker Conference in Shanghai	04/25/2019
New Data Show BluePrint® Identifies Estrogen Receptor Positive Breast Cancer Patients with Poor Response to Anti-Estrogen Therapy Who May Benefit from Neoadjuvant Chemotherapy	04/24/2019
Velabs Therapeutics to Cooperate with Chiome Bioscience in the Field of GPCR-Specific Functional Antibody Screening	04/24/2019
Vetter's Skokie Facility Expansion Nears Completion	04/16/2019
Novel First-In-Class FLIP Inhibitors for the Treatment of Cancer	03/28/2019
ProteoNic Biotechnology Licenses Protein Production Technology to Bayer	03/28/2019
BCG Digital Ventures and Sartorius Help Launch the World’s First Voice-Powered Digital Assistant for Scientists	03/28/2019
Tasly Pharmaceutical Group Taps Shuwen Biotech for Companion Diagnostic Services	03/28/2019
ambr® 15 Fermentation and ambr® 250 High Throughput Systems Now Available with Integrated Online Biomass Measurement for Microbial Applications	03/27/2019
EUR 3 Million in Series A for the Growth and Development of Cytena GmbH	03/26/2019
Implandata Successfully Gains CE Mark for Next-Generation EyeMate System and Poised for European-Wide Market Launch	03/25/2019
AlzProtect Starts Collaboration with PAREXEL Biotech for Phase 2a of AZP2006 for the Treatment of Progressive Supranuclear Palsy (PSP)	03/22/2019
Customers’ Experience Leads to a Highly Successful Outcome for Vetter at the 2019 CMO Leadership Awards	03/21/2019
AB2 Bio Announces Readiness for Recruitment in Pivotal Phase 3 Trial of Tadekinig Alfa, a Novel Human Recombinant Interleukin-18 Binding Protein, in Children with Genetic Diagnosis of NLRC4-MAS Mutation or XIAP Deficiency, with Amended Design in the U.S.	03/21/2019
Lead Pharma Announces Start of Phase I Clinical Trials with SAR441169 Candidate Treatment for Psoriasis	03/21/2019
Domainex and SpiroChem Enter a Fragment Drug Discovery Partnership	03/20/2019
SOTIO’s DCVAC/OvCa Significantly Improves Survival in Patients with Recurrent Ovarian Cancer	03/19/2019
Cellesce Announces License Agreement with Hubrecht Organoid Technology (HUB) for the Expansion of Breast Cancer Organoids at Scale	03/18/2019
Deuterium Depletion is a Disruptive Innovation in the Pharma Industry - HYD Pharma Develops New Deuterium-Depleted Drugs for the Treatment of Neoplastic and Metabolic Diseases	03/13/2019
NBE to Present Late-Breaking Abstract on Lead ADC Program NBE-002 (ROR1) at the AACR Annual Meeting	03/13/2019
Third Sartorius Research Xchange Forum 2019 Focuses on CAR-T Cell Therapy	03/08/2019
Potential New Treatment for Heart Attack	03/07/2019
SOTIO to Present Final Phase II DCVAC/OvCa Data at the 2019 SGO Annual Meeting on Women's Cancer	03/07/2019
Adult Stem Cell-Derived Kidney-on-a-Chip in Nature Biotechnology	03/05/2019

Page 26 of 84